Capoten Related Published Studies
Well-designed clinical trials related to Capoten (Captopril)
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial). [2009.07.15]
Lack of interaction between the peptidomimetic substrates captopril and cephradine. [2009.03]
Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. [2008.04.01]
[A comparison of the effect of oral captopril and nicardipine in hypertensive crisis] [2008.02]
Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women. [2007.08]
Effect of intraurethral captopril gel on the recurrence of urethral stricture after direct vision internal urethrotomy: Phase II clinical trial. [2007.03]
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). [2006.02.21]
Captopril effect on prostaglandin E2, thromboxane B2 and proteinuria in lupus nephritis patients. [2005.12]
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). [2005.11.29]
Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure. [2005.08]
Pentoxifylline is as effective as captopril in the reduction of microalbuminuria in non-hypertensive type 2 diabetic patients--a randomized, equivalent trial. [2005.08]
Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II). [2005.07]
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. [2005.06.28]
Captopril administered at night restores the diurnal blood pressure rhythm in adequately controlled, nondipping hypertensives. [2005.05]
Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus. [2005]
Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial. [2004.08]
Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP). [2004.03]
Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy. [2004.03]
Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis. [2004.01]
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. [2003.11.13]
[Changes of plasma fibrinolysis system and the effect of captopril in high altitude pulmonary edema] [2003.09]
Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with Wilson's disease. [2003.07]
Effects of captopril administration on pulmonary haemodynamics and tissue oxygenation during exercise in ACE gene subtypes in patients with COPD: a preliminary study. [2003.07]
Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration. [2003.06]
Influence of captopril on symptomatic and hormonal responses to hypoglycaemia in humans. [2003.04]
Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial doppler ultrasonography during hypertensive crisis. [2003]
Effects of furosemide versus captopril on postprandial and orthostatic blood pressure and on cerebral oxygenation in patients > or = 70 years of age with heart failure. [2002.09.15]
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. [2002.09.07]
Comparison of benazepril-amlodipine and captopril-thiazide combinations in the management of mild-to-moderate hypertension. [2002.06]
Assessment of quality of life in a double-blind, randomized clinical trial of imidapril and captopril for hypertensive Chinese in Taiwan. [2002.05]
[Captopril in the treatment of acute myocardial infarction. Hypotension as an important clinical problem] [2002.04]
Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM). [2002.02]
Acute blood pressure response to trandolapril and captopril in patients with left ventricular dysfunction after acute myocardial infarction. [2002.02]
Comparison of perindopril versus captopril for treatment of acute myocardial infarction. [2002.01.15]
[Effect of songling xuemaikang capsule combined with captopril on quality of life in primary hypertension patients] [2001.09]
[Clinical study on therapeutic effects of treatment according to syndrome differentiation of traditional Chinese medicine combined with captopril on severe viral myocarditis complicated heart failure] [2001.07]
[Delayed cardioprotection of captopril in patients undergoing open heart surgery] [2001.02.28]
[The change of plasma level of endothelin-1 in patients with cor pulmonale and the effects of Captopril] [1999.06]
[Clinical effect of captopril in diabetic patients with complicated acute myocardial infarction] [1999.06]
Well-designed clinical trials possibly related to Capoten (Captopril)
The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. [2009.04]
Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension. [2008.12]
Sex differences in blood pressure response to antihypertensive therapy in Chinese patients with hypertension. [2008.12]
The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. [2008.11.20]
Combination pharmacological cardioversion of permanent atrial fibrillation in post-prosthetic mitral valve replacement outpatients: a novel approach for the treatment of atrial fibrillation. [2008.05]
Comparison of effects of combined ACE inhibitor and low-dose thiazide diuretic with ACE inhibitor alone on insulin action in patients with hypertension and Type 2 diabetes: a double-blind crossover study. [2008.05]
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus. [2008.04.01]
A randomized double-blind placebo-controlled trial to increase feasibility of dobutamine stress echocardiography in patients with hypertension. [2008.04]
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality. [2008.01]
Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study. [2008]
Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function. [2007.12]
Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension. [2007.10]
Blood pressure control and response rates with zofenopril compared with amlodipine in hypertensive patients. [2007.10]
An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension. [2007.10]
Comparison of home and office blood pressure in hypertensive patients treated with zofenopril or losartan. [2007.10]
A Randomized Double-blind Placebo-controlled Trial to Increase Feasibility of Dobutamine Stress Echocardiography in Patients with Hypertension. [2007.09.27]
Antihypertensive efficacy of zofenopril plus hydrochlorothiazide fixed combination for treatment in metabolic syndrome. [2007.09]
Acute effects of renin-angiotensin system blockade on arterial function in hypertensive patients. [2007.08]
Effect of Sulfhydryl and non-Sulfhydryl Angiotensin-Converting Enzyme Inhibitors on Endothelial Function in Essential Hypertensive Patients. [2007.04]
Usefulness of either or both left and right bundle branch block at baseline or during follow-up for predicting death in patients following acute myocardial infarction. [2007.03.01]
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: The VALIANT experience. [2007.03]
Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study. [2007.03]
Lercanidipine in the treatment of hypertension. [2007.03]
Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT trial. [2007.03]
Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report. [2007.02]
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy. [2006.10.10]
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. [2006.10]
Effects of early angiotensin-converting enzyme inhibition in patients with non-ST-elevation acute anterior myocardial infarction. [2006.09]
Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment. [2005.10]
Antianxiety treatment in patients with excessive hypertension. [2005.09]
[Systemic hypertension at emergency units. The use of symptomatic drugs as choice for management] [2005.08]
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT). [2005.08]
Soluble CD40 ligand in acute and chronic heart failure. [2005.06]
Differential cognitive outcomes in the Hypertensive Old People in Edinburgh study. [2005.03.15]
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk. [2005.03]
Clinical observation on Breviscapine in treating hypertension patients complicated with micro-albuminuria of renal impairment. [2005.03]
VALIANT (VALsartan In Acute myocardial iNfarcTion) trial. [2005.03]
Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. [2005.02]
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. [2004.12.14]
Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. [2004.11.08]
Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. [2004.11]
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. [2004.09.23]
BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction. [2004.09]
[Study of diagnostic criteria of intima-media thickening and effects of drugs on peripheral arteries] [2004.08.02]
Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. [2004.07]
Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. [2004.07]
Which patients with hypertension and atherosclerotic renal artery stenosis benefit from immediate intervention? [2004.02]
Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients. [2003.09]
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial. [2003.08]
Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction. [2003.06]
Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction. [2003.06]
Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. [2003.05.27]
Antihypertensive treatment and homocysteine concentrations. [2003.03]
Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. [2003.03]
ACE inhibitors or AT-1 antagonists - which is OPTIMAAL after acute myocardial infarction? [2003.03]
Exercise testing in hypertensive patients taking different angiotensin-converting enzyme inhibitors. [2003.02]
Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study. [2003.02]
Effects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertension. [2003.02]
Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study. [2003.01]
Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production. [2002.08]
Renal perfusion in blacks: alterations caused by insuppressibility of intrarenal renin with salt. [2002.08]
Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. [2002.06]
|
